Beijing Med-Pharm Chief Financial Officer Fred Powell: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Fred Powell is Chief Financial Officer for Beijing Med-Pharm Corp. (BMP), which offers end-to-end solutions - including pre-market entry analysis, clinical trial management, registration, marketing and distribution - to Western pharmaceutical companies interested in selling their products in China.
You may also be interested in...
Beijing Med-Pharm Chief Financial Officer Fred Powell: An Interview With PharmAsia News (Part 2 of 2)
Powell sat down recently with PharmAsia News to discuss the challenges that Western pharmaceuticals companies face when entering the Chinese market, the opportunities presented by China's recent economic boom, and the ways pharmaceutical companies can best navigate the evolving Chinese landscape. [Editor's note: Part 1 of this interview ran June 12.]
Beijing Med-Pharm Chief Financial Officer Fred Powell: An Interview With PharmAsia News (Part 2 of 2)
Powell discusses the importance of distribution in the Chinese pharmaceutical market, how China’s reimbursement situation contrasts with that of the U.S., and his firm’s approach to working with the countries regulators.